Genomic sequences of exported mycobacteria polypeptides, vectors containing them and applications to the diagnosis and prevention of tuberculosis
Abstract
screening recombinant vector, cloning and / or expression, characterized in that it replicates in mycobacteria and in that it contains a 1) a functional replicon in mycobacteria; 2) a selectable marker; 3) a cassette indicator comprising: a) a multiple cloning site (polylinker), b) optionally a terminator active transcription in mycobacteria, in upstream direction of the polylinker, c) a first nucleotide sequence encoding a marker export and / or secretion of protein, said nucleotide sequence lacking its initiation codon and its regulatory sequences, and d) in downstream direction, a second nucleotide sequence encoding a marker promoter activity contained in being cloned fragment, said nucleotide sequence lacking its initiation codon being.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
28 members in 13 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 9710404 | France | A | |
| 9711325 | France | A |
Members28
| Document | Office | Kind | |
|---|---|---|---|
| FR2767336A1 | France | A1 | |
| FR2767337A1 | France | A1 | |
| CA2301374A1 | Canada | A1 | |
| WO9909186A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU9076598A | Australia | A | |
| WO9909186A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1003888A2 | European Patent Office (EPO) | A2 | |
| FR2767336B1 | France | B1 | |
| FR2767337B1 | France | B1 | |
| JP2002534956A | Japan | A | |
| NZ503316A | New Zealand | A | |
| AU759724B2 | Australia | B2 | |
| NZ519053A | New Zealand | A | |
| US2004214165A1 | United States of America | A1 | |
| US2005158714A9 | United States of America | A9 | |
| NZ529503A | New Zealand | A | |
| US2007015173A1 | United States of America | A1 | |
| US7244613B2 | United States of America | B2 | |
| EP1003888B1 | European Patent Office (EPO) | B1 | |
| AT393828TThis record | Austria | T | |
| ATE393828T1 | Austria | T1 | |
| DE69839426D1 | Germany | D1 | |
| PT1003888E | Portugal | E | |
| DK1003888T3 | Denmark | T3 | |
| EP1950221A2 | European Patent Office (EPO) | A2 | |
| ES2306478T3 | Spain | T3 | |
| DE69839426T2 | Germany | T2 | |
| EP1950221A3 | European Patent Office (EPO) | A3 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Ceased due to non-payment of the annual feeCeasedREN | REN | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 98942748
Titles2
- German
- NUKLEOTIDSEQUENZEN, DIE FÜR SEKRETIERTE POLYPEPTIDE AUS MYCOBACTERIUM KODIEREN, VEKTOREN, DIE DIESE ENTHALTEN, UND ANWENDUNGEN ZUR DIAGNOSTIK UND VERHÜTUNG VON TUBERKULOSE
- English
- NUCLEOTIDE SEQUENCES CODING FOR SECRETATED POLYPEPTIDES FROM MYCOBACTERIUM, VECTORS CONTAINING THEM, AND APPLICATIONS FOR DIAGNOSIS AND PREVENTION OF TUBERCULOSIS
Classification
- CPC, 5
- C07K14/35
- A61K39/00
- A61P11/00
- A61P31/04
- A61P31/06
- IPC, 19
- A61K39 00
- A61K39 04
- A61K48 00
- A61P11 00
- A61P31 04
- A61P31 06
- C07K14 35
- C07K16 12
- C07K19 00
- C12N1 21
- C12N15 09
- C12N15 31
- C12N15 74
- C12P21 02
- C12Q1 02
- C12Q1 68
- C12R1 32
- G01N33 50
- G01N33 53